SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (325)8/8/1999 12:47:00 PM
From: Thomas Kirwin   of 422
 
$19.12 Short-Term Price Target

I expect the Trailing Twelve Months (TTM) eps to hit $0.51 after next quarter's expected $0.14 eps report which is $0.06 greater or 75% higher than October 5th, 1998 reported $0.08 eps.

$0.14eps is Stephanie Haggerty's, Register & Akers Analyst, 1st quarter estimate. IMHO it could be higher! Remember, Stephanie's 11 to 17 month stock price target is $28.00.

Immucor's short-term stock price may be calculated as follows:

30(PE) * $0.51 (TTM-EPS) = $15.30 plus a 25% growth premium of $3.82 giving us $19.12!

In fact, I just sold one of my only profitable internut stocks so as to have cash at the ready should Immucor's stock price dip below $13.

Go Immucor!

Best O'Luck,

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext